Hair loss. Androgenic alopecia, unspecified
Conditions
Interventions
Intervention 1: Control group: Patients are treated with CM injections in five sessions with an interval of one month each. Intervention 2: Control group: Patients are treated with laser caps three ti
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Androgenetic alopecia Type 2-4 Do not take topical or oral medication to treat alopecia in the last six months
Exclusion criteria
Exclusion criteria: Age under 18 years Pregnancy Breastfeeding History of malignant diseases Take any topical or systemic treatment during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of hair loss. Timepoint: Before treatment and one month after the last session. Method of measurement: Trichoscan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: One week after session. Method of measurement: Questionnaire and visit.;Satisfaction. Timepoint: One months after the last session. Method of measurement: Questionnaire and visit.;Tolerability. Timepoint: Each session after transplantation. Method of measurement: Questionnaire and visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and stem Cell Research Center, Tehran University of Medical Sciences
Outcome results
None listed